VIVO logo

Meridian Bioscience (VIVO) Operating Expenses

Annual Operating Expenses

$112.41 M
+$7.58 M+7.23%

September 30, 2022

Summary

Performance

1-Year Change

+7.23%

3-Year Change

+38.12%

5-Year Change

+40.25%

15-Year Change

+40.25%

VIVO Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$112.41 M
VIVO annual total operating expenses is currently at an all-time high

3-Year Low

$104.83 M
VIVO annual total operating expenses is currently +7.23% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVOexpensesmetrics:

Annual Total Expenses

$257.07 M
VIVO annual total expenses is $257.07 million

Annual Interest Expense

$1.19 M
VIVO annual interest expense is $1.19 million

Annual Income Tax

$11.86 M
VIVO annual income tax is $11.86 million

Annual Cost Of Goods Sold

$144.66 M
VIVO annual cost of goods sold is $144.66 million

Quarterly Operating Expenses

$24.68 M
-$2.69 M-9.82%

September 30, 2022

Summary

Performance

3-Month Change

-9.82%

1-Year Change

-21.48%

3-Year Change

+11.13%

5-Year Change

+13.8%

VIVO Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$32.27 M
VIVO quarterly total operating expenses is currently -23.51% below its historical high of $32.27 million

3-Year Low

$24.68 M
VIVO quarterly total operating expenses is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOexpensesmetrics:

Quarterly Total Expenses

$56.36 M
VIVO quarterly total expenses is $56.36 million

Quarterly Interest Expense

$220.00 K
VIVO quarterly interest expense is $220.00 thousand

Quarterly Income Tax

-$1.07 M
VIVO quarterly income tax is -$1.07 million

Quarterly Cost Of Goods Sold

$31.68 M
VIVO quarterly cost of goods sold is $31.68 million

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$112.41 M
VIVO annual total operating expenses is $112.41 million

Annual SGA

$88.42 M
VIVO annual SGA is $88.42 million

Annual D&A

$16.51 M
VIVO annual depreciation & amortization is $16.51 million

VIVO Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.2%-21.5%
3 y3 years+38.1%+11.1%
5 y5 years+40.3%+13.8%

VIVO Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-6.7%-23.5%at low
5 y5-yearat high-27.6%-23.5%-15.7%
alltimeall timeat high-97.9%-23.5%-95.9%

Meridian Bioscience Operating Expenses History

DateAnnualQuarterly
Sep 2022
$112.41 M(+7.2%)
$24.68 M(-9.8%)
Jun 2022
-
$27.37 M(-15.2%)
Mar 2022
-
$32.27 M(+11.7%)
Dec 2021
-
$28.88 M(-8.1%)
Sep 2021
$104.83 M(+10.9%)
$31.43 M(+29.6%)
Jun 2021
-
$24.26 M(-8.0%)
Mar 2021
-
$26.36 M(+5.3%)
Dec 2020
-
$25.04 M(+0.8%)
Sep 2020
$94.56 M(+16.2%)
$24.85 M(-3.3%)
Jun 2020
-
$25.71 M(+10.8%)
Mar 2020
-
$23.21 M(+11.6%)
Dec 2019
-
$20.80 M(-6.4%)
Sep 2019
$81.38 M(-10.3%)
$22.21 M(+13.8%)
Jun 2019
-
$19.52 M(+4.3%)
Mar 2019
-
$18.72 M(-11.0%)
Dec 2018
-
$21.02 M(-16.4%)
Sep 2018
$90.74 M(+13.2%)
$25.15 M(+18.9%)
Jun 2018
-
$21.15 M(-3.8%)
Mar 2018
-
$21.98 M(-2.2%)
Dec 2017
-
$22.47 M(+3.6%)
Sep 2017
$80.15 M(+8.8%)
$21.69 M(+7.3%)
Jun 2017
-
$20.21 M(+4.8%)
Mar 2017
-
$19.29 M(+1.8%)
Dec 2016
-
$18.95 M(-3.2%)
Sep 2016
$73.68 M(+11.9%)
$19.58 M(+2.1%)
Jun 2016
-
$19.17 M(+11.4%)
Mar 2016
-
$17.21 M(-4.4%)
Dec 2015
-
$18.00 M(+8.9%)
Sep 2015
$65.82 M(+1.5%)
$16.53 M(+3.8%)
Jun 2015
-
$15.93 M(-5.1%)
Mar 2015
-
$16.79 M(+1.3%)
Dec 2014
-
$16.57 M(+0.8%)
Sep 2014
$64.85 M(+1.8%)
$16.43 M(+2.0%)
Jun 2014
-
$16.11 M(+1.1%)
Mar 2014
-
$15.93 M(-2.8%)
Dec 2013
-
$16.38 M(-6.9%)
Sep 2013
$63.73 M(+8.5%)
$17.60 M(+17.9%)
Jun 2013
-
$14.93 M(-3.6%)
Mar 2013
-
$15.49 M(-1.4%)
Dec 2012
-
$15.71 M(+1.4%)
Sep 2012
$58.74 M(+3.8%)
$15.49 M(+7.3%)
Jun 2012
-
$14.44 M(-0.5%)
Mar 2012
-
$14.52 M(+1.6%)
Dec 2011
-
$14.29 M(+19.5%)
Sep 2011
$56.59 M(+22.2%)
$11.96 M(-21.4%)
Jun 2011
-
$15.22 M(+1.5%)
Mar 2011
-
$14.99 M(+4.0%)
Dec 2010
-
$14.41 M(+17.6%)
Sep 2010
$46.32 M(+5.3%)
$12.26 M(+8.6%)
Jun 2010
-
$11.29 M(+2.5%)
Mar 2010
-
$11.02 M(-6.1%)
Dec 2009
-
$11.73 M(-2.7%)
Sep 2009
$44.00 M(+4.4%)
$12.06 M(+11.7%)
Jun 2009
-
$10.79 M(+8.3%)
Mar 2009
-
$9.97 M(-10.9%)
Dec 2008
-
$11.19 M(+2.6%)
Sep 2008
$42.13 M(+5.6%)
$10.91 M(+6.0%)
Jun 2008
-
$10.29 M(-0.9%)
Mar 2008
-
$10.38 M(-1.7%)
Dec 2007
-
$10.56 M(+0.0%)
Sep 2007
$39.91 M(+5.6%)
$10.55 M(+7.6%)
Jun 2007
-
$9.81 M(-1.8%)
Mar 2007
-
$9.99 M(+4.6%)
Dec 2006
-
$9.55 M(-2.0%)
Sep 2006
$37.79 M(+9.3%)
$9.74 M(+3.0%)
Jun 2006
-
$9.46 M(-1.5%)
Mar 2006
-
$9.60 M(+6.9%)
Dec 2005
-
$8.98 M(+3.7%)
Sep 2005
$34.56 M
$8.66 M(-13.2%)
DateAnnualQuarterly
Jun 2005
-
$9.98 M(+19.1%)
Mar 2005
-
$8.38 M(+11.0%)
Dec 2004
-
$7.55 M(-10.8%)
Sep 2004
$31.02 M(+21.6%)
$8.46 M(+12.3%)
Jun 2004
-
$7.54 M(-6.4%)
Mar 2004
-
$8.05 M(+15.5%)
Dec 2003
-
$6.97 M(+3.1%)
Sep 2003
$25.50 M(+3.6%)
$6.76 M(+11.5%)
Jun 2003
-
$6.06 M(-3.4%)
Mar 2003
-
$6.28 M(-1.9%)
Dec 2002
-
$6.40 M(-14.0%)
Sep 2002
$24.60 M(-33.3%)
$7.44 M(+32.2%)
Jun 2002
-
$5.63 M(-3.5%)
Mar 2002
-
$5.83 M(+2.4%)
Dec 2001
-
$5.70 M(+4.3%)
Sep 2001
$36.90 M(+22.6%)
$5.46 M(-19.8%)
Jun 2001
-
$6.81 M(-16.1%)
Mar 2001
-
$8.12 M(+11.0%)
Dec 2000
-
$7.32 M(-14.7%)
Sep 2000
$30.10 M(+5.3%)
$8.58 M(+24.1%)
Jun 2000
-
$6.92 M(+5.1%)
Mar 2000
-
$6.58 M(-17.7%)
Dec 1999
-
$8.00 M(-2.5%)
Sep 1999
$28.60 M(+67.3%)
$8.20 M(+14.0%)
Jun 1999
-
$7.20 M(+14.2%)
Mar 1999
-
$6.30 M(-7.4%)
Dec 1998
-
$6.80 M(+54.5%)
Sep 1998
$17.10 M(+6.9%)
$4.40 M(+7.3%)
Jun 1998
-
$4.10 M(-8.9%)
Mar 1998
-
$4.50 M(+2.3%)
Dec 1997
-
$4.40 M(+12.8%)
Sep 1997
$16.00 M(+13.5%)
$3.90 M(-2.5%)
Jun 1997
-
$4.00 M(-2.4%)
Mar 1997
-
$4.10 M(+2.5%)
Dec 1996
-
$4.00 M(0.0%)
Sep 1996
$14.10 M(+12.8%)
$4.00 M(+11.1%)
Jun 1996
-
$3.60 M(+5.9%)
Mar 1996
-
$3.40 M(+6.3%)
Dec 1995
-
$3.20 M(-3.0%)
Sep 1995
$12.50 M(+11.6%)
$3.30 M(+3.1%)
Jun 1995
-
$3.20 M(+3.2%)
Mar 1995
-
$3.10 M(0.0%)
Dec 1994
-
$3.10 M(0.0%)
Sep 1994
$11.20 M(+30.2%)
$3.10 M(+24.0%)
Jun 1994
-
$2.50 M(+8.7%)
Mar 1994
-
$2.30 M(0.0%)
Dec 1993
-
$2.30 M(-4.2%)
Sep 1993
$8.60 M(+16.2%)
$2.40 M(+4.3%)
Jun 1993
-
$2.30 M(+4.5%)
Mar 1993
-
$2.20 M(+15.8%)
Dec 1992
-
$1.90 M(+11.8%)
Sep 1992
$7.40 M(+19.4%)
$1.70 M(-15.0%)
Jun 1992
-
$2.00 M(+5.3%)
Mar 1992
-
$1.90 M(+11.8%)
Dec 1991
-
$1.70 M(+6.3%)
Sep 1991
$6.20 M(+26.5%)
$1.60 M(-5.9%)
Jun 1991
-
$1.70 M(+13.3%)
Mar 1991
-
$1.50 M(+7.1%)
Dec 1990
-
$1.40 M(-12.5%)
Sep 1990
$4.90 M(+22.5%)
$1.60 M(+33.3%)
Jun 1990
-
$1.20 M(0.0%)
Mar 1990
-
$1.20 M(+20.0%)
Dec 1989
-
$1.00 M(0.0%)
Sep 1989
$4.00 M(+2.6%)
$1.00 M(0.0%)
Jun 1989
-
$1.00 M
Sep 1988
$3.90 M(+14.7%)
-
Sep 1987
$3.40 M(+36.0%)
-
Sep 1986
$2.50 M(+4.2%)
-
Sep 1985
$2.40 M
-

FAQ

  • What is Meridian Bioscience annual total operating expenses?
  • What is the all time high annual operating expenses for Meridian Bioscience?
  • What is Meridian Bioscience annual operating expenses year-on-year change?
  • What is Meridian Bioscience quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Meridian Bioscience?
  • What is Meridian Bioscience quarterly operating expenses year-on-year change?

What is Meridian Bioscience annual total operating expenses?

The current annual operating expenses of VIVO is $112.41 M

What is the all time high annual operating expenses for Meridian Bioscience?

Meridian Bioscience all-time high annual total operating expenses is $112.41 M

What is Meridian Bioscience annual operating expenses year-on-year change?

Over the past year, VIVO annual total operating expenses has changed by +$7.58 M (+7.23%)

What is Meridian Bioscience quarterly total operating expenses?

The current quarterly operating expenses of VIVO is $24.68 M

What is the all time high quarterly operating expenses for Meridian Bioscience?

Meridian Bioscience all-time high quarterly total operating expenses is $32.27 M

What is Meridian Bioscience quarterly operating expenses year-on-year change?

Over the past year, VIVO quarterly total operating expenses has changed by -$6.75 M (-21.48%)